Knight Therapeutics Stock Investor Sentiment

KHTRF Stock  USD 3.73  0.02  0.53%   
Roughly 62% of Knight Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Knight Therapeutics pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Knight Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Knight Therapeutics stock news signals to limit their universe of possible portfolio assets.
Knight Therapeutics pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Knight daily returns and investor perception about the current price of Knight Therapeutics as well as its diversification or hedging effects on your existing portfolios.
  
over six months ago at news.google.com         
Knight Therapeutics Inc. Insider Sime Armoyan Buys 6200 Shares - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Insider Buying Knight Therapeutics Inc. Insider Purchases 6,200 Shares of Stock - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Knight Therapeutics Inc Revenue Breakdown OTCKHTRF TradingView - TradingView
Google News at Macroaxis
over six months ago at news.google.com         
Knight Therapeutics Inc. Forecasted to Post Q1 2024 Earnings of Per Share - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Q1 2024 EPS Estimates for Knight Therapeutics Inc. Reduced by Analyst - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Royal Bank of Canada Raises Knight Therapeutics Price Target to C7.00 - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Knight Therapeutics Full Year 2023 Earnings Misses Expectations - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Knight Therapeutics Achieves Record Growth - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
Knight Therapeutics Inc. - Baystreet.ca
Google News at Macroaxis
over six months ago at news.google.com         
Raymond James Equities Analysts Lift Earnings Estimates for Knight Therapeutics Inc. - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Analysts Offer Predictions for Knight Therapeutics Inc.s Q4 2023 Earnings - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Brokers Issue Forecasts for Knight Therapeutics Inc.s FY2023 Earnings - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Knight Therapeutics Inc. Marks Decade of Pharmaceutical Innovation and Growth - BNN Breaking
Google News at Macroaxis
over six months ago at news.google.com         
Knight Therapeutics Inc. Announces Regulatory Submission of Fostamatinib in Brazil - Marketscreener....
Google News at Macroaxis
over six months ago at news.google.com         
Closing Bell Knight Therapeutics Inc down on Tuesday - Barchart
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Knight Therapeutics that are available to investors today. That information is available publicly through Knight media outlets and privately through word of mouth or via Knight internal channels. However, regardless of the origin, that massive amount of Knight data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Knight Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Knight Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Knight Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Knight Therapeutics alpha.

Knight Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Knight Pink Sheet analysis

When running Knight Therapeutics' price analysis, check to measure Knight Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Knight Therapeutics is operating at the current time. Most of Knight Therapeutics' value examination focuses on studying past and present price action to predict the probability of Knight Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Knight Therapeutics' price. Additionally, you may evaluate how the addition of Knight Therapeutics to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Global Correlations
Find global opportunities by holding instruments from different markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal